logo-loader
LSE:OXB

Oxford BioMedica PLC

Receive alerts
Market:
LSE
Price
198.00 GBX
Day Change
0.41%
Market Cap:
£197.92 m
52 weeks high
474.50
52 weeks low
164.29

In brief

Oxford BioMedica is a biopharmaceutical company specialising in the development and commercialisation of innovative gene-based medicines. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange.

Oxford BioMedica's products use genes as the mediators of a therapeutic effect and/or immune response. The company has a platform of gene delivery technologies, which are predominately based on highly engineered viral systems. Oxford BioMedica has core expertise in gene delivery, as well as in-house clinical, regulatory and manufacturing know-how.